HIGHLIGHTS
- who: Ke Shi and colleagues from the University of Wisconsin-Madison, United States have published the research work: Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis, in the Journal: (JOURNAL)
- what: The model for end-stage liver disease (MELD) and Child-Turcotte-Pugh (CTP) scores were used to estimate the severity of the liver disease (Wiesner et_al, 2003; Botero and Lucey, 2003).
- future: Prospective studies are required to confirm the preventive effects of probiotics against HCC. reported that probiotics prevent carcinogenesis by producing SCFAs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.